GlassScriptPhysician profile
Thomas W Lee
NPI 1285614693
$929.94
in general payments reported to CMS, 2019-2025
17 companies · $54.48 in 2025
The $54.48 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $159 · 2021: $177 · 2022: $72.25 · 2023: $174 · 2024: $188 · 2025: $54.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $124.95 | 2020 | |
| Pfizer INC. | $110.47 | 2019-2023 | |
| Novo Nordisk INC | $109.38 | 2021 | |
| Astellas Pharma US INC | $108.75 | 2023-2024 | Veozah |
| Gilead Sciences, INC. | $89.20 | 2024 | |
| Abbvie INC. | $62.53 | 2019 | |
| Avion Pharmaceuticals | $54.74 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $42.56 | 2023 | Myfembree |
| Exeltis, USA INC. | $42.11 | 2023-2025 | Slynd |
| Exact Sciences Corporation | $36.91 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Smith+Nephew, INC. | $32.75 | 2024 | Pico 14 |
| Avanos Medical | $29.73 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.79 | 2023 | |
| Therapeuticsmd, INC. | $17.70 | 2021 | |
| Aspira Women'S Health INC | $17.00 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $16.50 | 2019 | |
| Acella Pharmaceuticals, LLC | $14.87 | 2023 | Divigel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.